Navigantis is creating a surgical robotic for a variety of neurovascular indications, together with acute ischemic stroke. | Supply: Navigantis
Navigantis Inc. final week introduced the primary profitable scientific procedures carried out with its Vasco surgical robotic for sufferers affected by neurovascular issues. The interventional circumstances concerned sufferers present process diagnostic cerebral angiogram, mind tumor embolization, and mechanical thrombectomy for ischemic stroke.
“This achievement marks an essential milestone in our mission to introduce some great benefits of robotic procedures to the interventional neurovascular discipline,” acknowledged Mor Dayan, CEO of Navigantis.
“The Vasco robotic platform has the potential to redefine how we strategy essentially the most advanced and time-sensitive neurovascular procedures, finally bettering each affected person outcomes and procedural efficiencies,” he added. “This is likely one of the first steps in direction of enabling robotic telesurgery for stroke sufferers, which might dramatically scale back response instances and improve entry to well timed important care.”
Neurovascular ailments require well timed therapy
Neurovascular ailments, together with stroke, aneurysms, and arteriovenous malformations (AVMs) are main causes of loss of life and incapacity worldwide, in keeping with Navigantis. Strokes have an effect on somebody within the U.S. each 40 seconds, and they’re the main reason behind incapacity.
Mechanical thrombectomy (MT) is now the “gold commonplace” for acute ischemic stroke, famous the Miami-based firm. If a affected person receives MT inside two hours from the onset of signs, she or he has a 90% probability of re-achieving independence. At six hours, the quantity drops to 30%.
Navigantis asserted that these numbers reaffirm the significance of making certain that procedures are well timed and extensively obtainable. They’re at present constrained by the inadequate variety of educated neuro-interventionalists and the restricted entry exterior city areas.
Regardless of enhancements in stroke methods of care, many Individuals nonetheless lack well timed entry to acute stroke intervention, Navigantis stated.
Register right now to avoid wasting 40% on convention passes!
Navigantis takes steps to extra advanced surgical procedure
Based in 2022, Navigantis has developed an interventional robotic platform for a variety of neurovascular procedures and indications, together with acute ischemic stroke. VASCO is an investigational gadget and is at present present process scientific analysis exterior the U.S. It’s not accredited for industrial use in any jurisdiction, together with the U.S.
As extra endovascular procedures requiring fluoroscopy for imaging steerage are carried out to deal with neurovascular ailments, it has develop into vitally essential to deal with reducing radiation publicity. The applying of robotics for interventional procedures will significantly scale back it, Navigantis stated.
Prof. Dong Joon Kim, a pioneer within the robotic neuro-interventional house and the chairman of radiology at Severance Hospital in Seoul, South Korea, led the research.
“These first profitable robotic circumstances are a serious stepping stone in direction of treating extra advanced neurovascular ailments,” stated Prof. Kim.
The corporate stated this achievement builds on its earlier first-in-human (FIH) trials in 2022, by which physicians used the earlier technology of VASCO to efficiently carry out robotic embolization of liver tumors.
In July 2024, Navigantis closed a $12 million Sequence A funding spherical. The corporate stated proceeds from the financing will probably be used to assist the continued growth and testing of the robotic to convey VASCO to FIH scientific trials for neurovascular procedures.
The Navigantis crew on the Society of Robotic Surgical procedure. From left to proper: Hyosig Kang, the co-founder and CTO; Mor Dayan, co-founder and CEO; and Marc Camprubí Artal, head of operations. | Supply: Navigantis through LinkedIn
